'ILC Therapeutics' CEO Owain Millington has authored an article in the winter issue of Drug Discovery World, on some of the areas of unmet need in infectious disease, and where the search for pleiotropic, broad-spectrum antivirals could lead drug development.
Press releases
Keeping you updated